Quotient Ltd

Delisted

CIK 1596946fmd_13VVZXTXGMR618RBJW0C27HK3CManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Apr 01, 2012 to Dec 31, 2022, 40 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.